Exelon Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 8.60 B

Exelon Corporation EBITDA is USD 8.60 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 8.45% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Exelon Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 7.93 B, a 7.26% change year over year.
  • Exelon Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 7.39 B, a -34.00% change year over year.
  • Exelon Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 11.20 B, a 3.45% change year over year.
  • Exelon Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 10.83 B, a 8.76% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)